long-term treatment [hlca]
Added [ftcn]
Conventional Therapy [topp]
Drug [phsu]
Apheresis [topp]
Patients [podg]
Homozygous [orga]
familial [famg]
Hypercholesterolaemia [dsyn]
Interim [tmco]
Subset Analysis [resa]
OPEN LABEL [resa]
Study [mnob]
Homozygous [orga]
Familial hypercholesterolaemia [dsyn]
Genetic Disorder [dsyn]
Raised [qnco]
Cholesterol, LDL [bacs, strd]
Reduced [qlco]
LDL Receptor [aapp, rcpt]
function [phsf]
Xanthomas [dsyn]
Cardiovascular disease [dsyn]
Age-Years [tmco]
Conventional Therapy [topp]
Statins [orch, phsu]
ezetimibe [orch, phsu]
Apheresis [topp]
Safety [hcpp]
Efficacy [qlco]
proprotein convertase subtilisin/kexin type 9 [gngm]
Inhibitor [qlco]
Subset [clas]
Patients [podg]
Homozygous [orga]
Familial hypercholesterolaemia [dsyn]
OPEN LABEL [resa]
Phase 3 [tmco]
Trial [resa]
Methods [inpr]
Interim [tmco]
Subset Analysis [resa]
Study [mnob]
Sites [spco]
Countries [geoa]
included [ftcn]
Patients [podg]
Aged [orga]
Old [tmco]
Homozygous [orga]
Familial hypercholesterolaemia [dsyn]
Stable [qlco]
Cholesterol, LDL [bacs, strd]
lowering [spco]
therapy [ftcn]
weeks [tmco]
Patients [podg]
Received [qlco]
mg% [qnco]
Monthly [tmco]
If [qlco]
Apheresis [topp]
2 Weeks [tmco]
Increased [qnco]
2 Weeks [tmco]
weeks [tmco]
Patients [podg]
Apheresis [topp]
Primary [qlco]
Study [mnob]
treatment [ftcn]
emergent [idcn]
adverse events [fndg]
secondary [neop]
effects [qlco]
Cholesterol, LDL [bacs, strd]
Lipids [lipd]
Patients [podg]
Basis [ftcn]
Statistical [ocdi]
Comparison [acty]
Post [tmco]
Interim [tmco]
Study [mnob]
Registered [hlca]
GOV [gngm]
ONGOING [idcn]
findings [ftcn]
Patients [podg]
included [ftcn]
Receive [qlco]
Apheresis [topp]
Study [mnob]
Entry [inpr]
Young [tmco]
Cutoff [ftcn]
Date [tmco]
1-7 [gngm]
SD [fndg]
weeks [tmco]
Cholesterol, LDL [bacs, strd]
Decreased [qnco]
baseline [bodm]
SD [fndg]
Absolute [qlco]
Decrease [qlco]
mmol/L [qnco]
SD [fndg]
reductions [npop]
Maintained [ftcn]
Patients [podg]
Apheresis [topp]
Study [mnob]
Entry [inpr]
Increased [qnco]
2 Weeks [tmco]
Additional [ftcn]
reduction [npop]
Cholesterol, LDL [bacs, strd]
SD [fndg]
Absolute [qlco]
Decrease [qlco]
mmol/L [qnco]
SD-1 [imft]
P NOS [aapp, imft]
Post [tmco]
reductions [npop]
Cholesterol, LDL [bacs, strd]
Patients [podg]
Apheresis [topp]
P NOS [aapp, imft]
P NOS [aapp, imft]
reductions [npop]
Patients [podg]
Apheresis [topp]
P NOS [aapp, imft]
P NOS [aapp, imft]
Note [clna]
Small [qnco]
reduction [npop]
Lipoprotein (a) [aapp, bacs]
P NOS [aapp, imft]
Additional [ftcn]
reduction [npop]
P NOS [aapp, imft]
Cholesterol, HDL [bacs, lipd]
Increased [qnco]
SD-1 [imft]
P NOS [aapp, imft]
SD [fndg]
P NOS [aapp, imft]
Well [qlco]
Patients [podg]
Reported [inpr]
treatment [ftcn]
emergent [idcn]
adverse events [fndg]
Minor [popg]
Nasopharyngitis [dsyn]
Patients [podg]
Influenza [dsyn]
Headache [sosy]
Upper respiratory tract infection [dsyn]
Serious Adverse Event [fndg]
Occurred [acty]
Patients [podg]
cardiovascular events [fndg]
Patients [podg]
deaths [orgf]
cardiovascular events [fndg]
Patients [podg]
Apheresis [topp]
Patients [podg]
Receive [qlco]
Apheresis [topp]
Interpretation [inpr]
Interim [tmco]
Suggest [idcn]
effective [qlco]
Additional [ftcn]
Option [ftcn]
Cholesterol, LDL [bacs, strd]
Patients [podg]
Homozygous [orga]
Familial hypercholesterolaemia [dsyn]
Apheresis [topp]
